Table 3.
Variablea | Coefficient ± SE | Odds Ratio (68% CI) | P | Reliability (%)b |
---|---|---|---|---|
Higher likelihood of isolated AS | ||||
Larger BMIc | 0.34 ± 0.094 | —a | .0003 | 82 |
Shortness of breath | 0.29 ± 0.10 | 1.3 (1.2, 1.5) | .006 | 97 |
COPD | 0.22 ± 0.11 | 1.2 (1.1, 1.4) | .05 | 41 |
Higher aortic valve peak gradientd | −0.85 ± 0.098 | —a | <.0001 | 100 |
Bicuspid aortic valve | 0.56 ± 0.092 | 1.8 (1.6, 1.9) | <.0001 | 100 |
Tricuspid valve regurgitation 3+/4+ | 0.45 ± 0.20 | 1.6 (1.3, 1.9) | .02 | 64 |
Higher diastolic blood pressuree | −0.20 ± 0.085 | —a | .02 | 74 |
Higher likelihood of AS+CAD | ||||
Older agef | 2.2 ± 0.32 | —a | <.0001 | 89 |
Male | 0.78 ± 0.087 | 2.2 (2.0, 2.4) | <.0001 | 98 |
Higher NYHA functional class | 0.25 ± 0.053 | 1.3 (1.2, 1.4) | <.0001 | 99 |
Lower ejection fractiong | −0.42 ± 0.12 | —a | .0005 | 98 |
Peripheral arterial disease | 0.58 ± 0.16 | 1.8 (1.5, 2.1) | .0002 | 82 |
Carotid disease | 0.63 ± 0.078 | 1.9 (1.7, 2.03) | <.0001 | 100 |
Hypertension | 0.54 ± 0.088 | 1.7 (1.6, 1.9) | <.0001 | 100 |
Higher systolic blood pressureh | 0.33 ± 0.15 | —a | .03 | 74 |
Diabetes | 0.47 ± 0.099 | 1.6 (1.4, 1.8) | <.0001 | 100 |
Lower hematocriti | −0.90 ± 0.28 | —a | .001 | 81 |
Lower HDLj | −0.60 ± 0.14 | —a | <.0001 | 100 |
Aorta procedure | 0.43 ± 0.19 | 1.5 (1.3, 1.9) | .02 | 81 |
See eFigure 4 for an illustration of the nature of the relationship of continuous variables to likelihood of having coronary artery disease.
Percent of times variables appeared in 250 bootstrap models.
(BMI/30)2, squared transformation.
(80/AV peak gradient), inverse transformation.
(75/diastolic blood pressure)2, inverse squared transformation.
Log(age), logarithmic transformation.
(Ejection fraction/55)2, squared transformation.
(Systolic blood pressure/135)2, squared transformation.
Log(hematocrit), logarithmic transformation.
Log(HDL), logarithmic transformation.
Key: AS, aortic stenosis; BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association; HDL, high-density lipoprotein; SE, standard error.